[1]
|
NUCLEOTIDE SEQUENCE [MRNA].
TISSUE=Liver;
PubMed=2830248 [NCBI, ExPASy, EBI, Israel, Japan]
Tone M.,
Kikuno R.,
Kume-Iwaki A.,
Hashimoto-Gotoh T.;
"Structure of human alpha 2-plasmin inhibitor deduced from the cDNA sequence.";
J. Biochem. 102:1033-1041(1987).
|
[2]
|
NUCLEOTIDE SEQUENCE [GENOMIC DNA].
PubMed=3166140 [NCBI, ExPASy, EBI, Israel, Japan]
Hirosawa S.,
Nakamura Y.,
Miura O.,
Sumi Y.,
Aoki N.;
"Organization of the human alpha 2-plasmin inhibitor gene.";
Proc. Natl. Acad. Sci. U.S.A. 85:6836-6840(1988).
|
[3]
|
ERRATUM.
Hirosawa S.,
Nakamura Y.,
Miura O.,
Sumi Y.,
Aoki N.;
Proc. Natl. Acad. Sci. U.S.A. 86:1612-1613(1989).
|
[4]
|
NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT VAL-2.
DOI=10.1101/gr.2596504; PubMed=15489334 [NCBI, ExPASy, EBI, Israel, Japan]
The MGC Project Team;
"The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).";
Genome Res. 14:2121-2127(2004).
|
[5]
|
NUCLEOTIDE SEQUENCE [MRNA] OF 4-491.
PubMed=2433286 [NCBI, ExPASy, EBI, Israel, Japan]
Holmes W.E.,
Nelles L.,
Lijnen H.R.,
Collen D.;
"Primary structure of human alpha 2-antiplasmin, a serine protease inhibitor (serpin).";
J. Biol. Chem. 262:1659-1664(1987).
|
[6]
|
PROTEIN SEQUENCE OF 28-58.
TISSUE=Plasma;
PubMed=8484741 [NCBI, ExPASy, EBI, Israel, Japan]
Bangert K.,
Johnsen A.H.,
Christensen U.,
Thorsen S.;
"Different N-terminal forms of alpha 2-plasmin inhibitor in human plasma.";
Biochem. J. 291:623-625(1993).
|
[7]
|
PROTEIN SEQUENCE OF 28-52.
TISSUE=Plasma;
DOI=10.1016/0014-5793(92)81419-M; PubMed=1385210 [NCBI, ExPASy, EBI, Israel, Japan]
Christensen S.,
Sottrup-Jensen L.;
"Bovine alpha 2-antiplasmin. N-terminal and reactive site sequence.";
FEBS Lett. 312:100-104(1992).
|
[8]
|
PROTEIN SEQUENCE OF 40-491.
DOI=10.1111/j.1432-1033.1987.tb13551.x; PubMed=2440681 [NCBI, ExPASy, EBI, Israel, Japan]
Lijnen H.R.,
Holmes W.E.,
van Hoef B.,
Wiman B.,
Rodriguez H.,
Collen D.;
"Amino-acid sequence of human alpha 2-antiplasmin.";
Eur. J. Biochem. 166:565-574(1987).
|
[9]
|
PROTEIN SEQUENCE OF 40-43.
DOI=10.1111/j.1432-1033.1977.tb11709.x; PubMed=21075 [NCBI, ExPASy, EBI, Israel, Japan]
Wiman B.,
Collen D.;
"Purification and characterization of human antiplasmin, the fast-acting plasmin inhibitor in plasma.";
Eur. J. Biochem. 78:19-26(1977).
|
[10]
|
NUCLEOTIDE SEQUENCE [MRNA] OF 218-491.
PubMed=3818581 [NCBI, ExPASy, EBI, Israel, Japan]
Sumi Y.,
Nakamura Y.,
Aoki N.,
Sakai M.,
Muramatsu M.;
"Structure of the carboxyl-terminal half of human alpha 2-plasmin inhibitor deduced from that of cDNA.";
J. Biochem. 100:1399-1402(1986).
|
[11]
|
PROTEIN SEQUENCE OF 481-491, AND SULFATION.
PubMed=2434496 [NCBI, ExPASy, EBI, Israel, Japan]
Hortin G.,
Fok K.F.,
Toren P.C.,
Strauss A.W.;
"Sulfation of a tyrosine residue in the plasmin-binding domain of alpha 2-antiplasmin.";
J. Biol. Chem. 262:3082-3085(1987).
|
[12]
|
ACTIVE SITES.
PubMed=2456616 [NCBI, ExPASy, EBI, Israel, Japan]
Potempa J.,
Shieh B.-H.,
Travis J.;
"Alpha-2-antiplasmin: a serpin with two separate but overlapping reactive sites.";
Science 241:699-700(1988).
|
[13]
|
DISULFIDE BOND.
PubMed=9169621 [NCBI, ExPASy, EBI, Israel, Japan]
Christensen S.,
Valnickova Z.,
Thogersen I.B.,
Olsen E.H.,
Enghild J.J.;
"Assignment of a single disulphide bridge in human alpha2-antiplasmin: implications for the structural and functional properties.";
Biochem. J. 323:847-852(1997).
|
[14]
|
GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-126; ASN-295 AND ASN-309, AND MASS SPECTROMETRY.
TISSUE=Plasma;
DOI=10.1021/pr0502065; PubMed=16335952 [NCBI, ExPASy, EBI, Israel, Japan]
Liu T.,
Qian W.-J.,
Gritsenko M.A.,
Camp D.G. II,
Monroe M.E.,
Moore R.J.,
Smith R.D.;
"Human plasma N-glycoproteome analysis by immunoaffinity subtraction, hydrazide chemistry, and mass spectrometry.";
J. Proteome Res. 4:2070-2080(2005).
|
[15]
|
VARIANT APLID GLU-176 DEL.
PubMed=2572590 [NCBI, ExPASy, EBI, Israel, Japan]
Miura O.,
Sugahara Y.,
Aoki N.;
"Hereditary alpha 2-plasmin inhibitor deficiency caused by a transport-deficient mutation (alpha 2-PI-Okinawa). Deletion of Glu137 by a trinucleotide deletion blocks intracellular transport.";
J. Biol. Chem. 264:18213-18219(1989).
|
[16]
|
VARIANT APLID MET-411, AND VARIANTS VAL-27; TRP-33 AND LYS-434.
DOI=10.1046/j.1365-2141.1999.01708.x; PubMed=10583218 [NCBI, ExPASy, EBI, Israel, Japan]
Lind B.,
Thorsen S.;
"A novel missense mutation in the human plasmin inhibitor (alpha2-antiplasmin) gene associated with a bleeding tendency.";
Br. J. Haematol. 107:317-322(1999).
|
|
ExPASy Home page
APAF Australia
